I promise

"I promise, Suzy... Even if it takes the rest of my life." - Nancy G. Brinker, founder of Susan G. Komen for the Cure

What is Triple Negative Breast Cancer?


Just in recent years, Triple Negative Breast Cancer has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" type of cancer. Being Triple Negative, you don't have a targeted therapy and that your only treatment option is chemotherapy.

Triple Negative is seen in about 15% of all breast cancers. Triple Negative is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TN is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Carpe diem

Seize Each new Day with Renewed Strength,
Believe in Yourself, Go forward with
Courage and faith
to face whatever Tomorrow may bring.

Chicks For Charity motto:

Enjoy life. Laugh a lot.
Work hard. Play hard.
Be thankful for our blessings.
Share the wisdom. Give back

Wednesday, March 2, 2016

Triple Negative Breast Cancer Awareness Day is March 3, 2016

Triple Negative Breast Cancer Day is the only global event dedicated to raising both awareness and funds exclusively for triple negative breast cancer.

Thursday is Triple Negative Breast Cancer (TNBC) Awareness Day, and I'll be holding my annual online fundraising campaign for TNBC Foundation where 100% donation goes directly to TNBC research. Please consider a donation today to support my cause that I am very passionate about. 
Thank you, Melissa Paskvan

"Alone we can do so little, Together we can do so much more." - Helen Kelle

Toledo, Ohio Event - A Different Shade of Pink 


  1. Dear Ms. Paskvan,

    I am a Professor of Medicine/Hematology at the University of Washington and direct the Center for Cancer Innovation, where we have two clinical trials. Our first is a trial for patients with metastatic triple negative breast cancer that has been described in a recent publication that can be found here:http://www.jnccn.org/content/14/1/8.long

    Our second trial involves a recently developed a web based tool called the Tumor Crowd Modeling Platform (cci.washington.edu). The TCMP allows cancer patients to upload their de-identified clinical, molecular and other laboratory data for comments by experts from around the world. In order for the TCMP to achieve its potential I am convinced that we need to commercialize it, and am trying to gauge the level of interest that cancer patients might have in this type of platform.

    Might I ask you check out TCMP in its current form? The level of discussion is quite sophisticated, and clearly isn’t suitable for everyone. But I suspect that there will be a significant fraction of patients (cancer nerds) that might find the caliber of discussion interesting and helpful. As it turns out I learned this past April that I have myeloma, and am patient 1 on the platform.

    I would greatly appreciate any thoughts you might have. Please feel free to call me anytime on my cell at 206 412 1787. Thanks very much for considering this.

    Tony Blau

  2. This comment has been removed by a blog administrator.


Note: Only a member of this blog may post a comment.

Total Pageviews

Click to help fund mammograms for the uninsured

The Breast Cancer Site

Click to join me in support group

Inspire health and wellness support groups

Triple Negative Breast Cancer Foundation

Triple Negative Breast Cancer Foundation
"click image to link"

"Click image to link"

The SCAR Project

The SCAR Project
"Click image to link"


"Click image to link"

Breast Cancer Awareness Body Painting Project

Breast Cancer Awareness Body Painting Project
"Click image to link"